Chiesi USA, Inc. recalls CLEVIPREX (clevidipine injectable emulsion)…
Chiesi USA, Inc. recalls CLEVIPREX (clevidipine injectable emulsion) 50 mg/100 mL (0.5 mg/mL)
- Published
- 22 Jul 2026
- Units affected
- 44280 vials
- Agency
- FDA
- Country
- United States
The hazard
Lack of Assurance of Sterility
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
CLEVIPREX (clevidipine injectable emulsion) 50 mg/100 mL (0.5 mg/mL), 10 Single Use Vials, Rx Only, Manufactured for: Chiesi USA, Inc., Cary, NC 27518, by Fresenius Kabi, Graz, Austria, NDC 10122-611-10.
- Brand / company
- Chiesi USA, Inc.
- Codes / lots
- Lot #: 1239521, 1237454, Exp. Date 10/2027
- Distribution
- Nationwide within the United States
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 22 Jul 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.